Objective: To determine the molecular characterization and disease-associated complications of beta-thalassemia intermedia (-TI) patients in Sulaymaniyah province, northeastern Iraq.
Methods: A total of 159 -TI) patients in Sulaymaniyah province, northeastern Iraq. -TI) patients in Sulaymaniyah province, northeastern Iraq.